Pharmacy Today September 2015

September 2015 | Volume 21 Number 9

Drugs & Diseases

25  Showcase: New approvals, indications, generic, app; more

28  OTCs Today: 
OTCs and older patients

29  OTC Survey: Complementary therapies

30  Immunization Update: Award winners offer advice

37  One to One: Boomers and medical cannabis use

38  Integrative Medicine: Apoaequorin for 
memory enhancement?

39  Conference Roundup: Alzheimer disease, 
insomnia, supplement use

40  Focus on Geriatrics: 
Preview of Beers update 
and the year’s key research

42  Alirocumab: New class of lipid-lowering drugs

44  Lumacaftor/Ivacaftor: Combination therapy for cystic fibrosis

46  Sacubitril/Valsartan: First neprilysin inhibitor for HF

48  Brexpiprazole: New atypical antipsychotic approved

49  Heroin Addiction: Epidemic linked to prescription opioids

Practice & Trends

50  Innovations: Credentialing and privileging of pharmacists 

54  MTM Pearls: Call to action for community pharmacists 

56  Technology Forum: Social networks in health care

58  Collaborative Practice Agreements: NASPA workgroup releases recommendations

60  REMS Programs: New and improved FDA online resource

61  Gaming in Education: AACP keynote 

62  Compounding Law: Update on outsourcing facilities

64  CVS Health and IBM: Using Watson to improve chronic disease outcomes

96  Error Alert: Preventing 
ADEs in older adults

Special Pain Section

65  Editorial: Boots on the ground

66  Pain Management 101: Principles for complex issue

68  Screening Prescriptions: VIGIL process for safe use

70  Education: Patients, providers can benefit

Laws, Regs & Rulings

72  On the Docket: Destruction of evidence following error

74  Hub on Provider Status

      74  Supporting provider status during American Pharmacists Month

      76  Provider status profile: Sangalang makes big impact with small swap

78  Naloxone: Federal, state recognition for pharmacists

In This Issue

4  News You Can Use: 
USNS Mercy; Today’s 20th; provider status advocacy update; Tricare; 50 years of Medicare, Medicaid 

6  Correction

8  Today’s Perspective: Board of Pharmacy Specialties

12  Pharmacists in Action: APhA offers tools, solutions; APhA Election; patient safety

24  APhA DrugInfoLine: Once-weekly dulaglutide beats out insulin glargine in type 2 diabetes

Health-System Edition

HSE 5  Insomnia
: Sodium chloride shortage

HSE 6  Technology: 
Data key to future of profession

HSE 8  Better Outcomes: 
Pharmacist services in ACOs

HSE 10 Med Safety
: Strategies for hospital pharmacists